Tralokinumab Antibody
Tralokinumab is a high-affinity, fully human IgG4 monoclonal antibody that selectively neutralizes IL-13. By blocking IL-13 receptor interaction and downstream signaling, it serves as a key research tool for investigating the mechanisms and treatment of atopic dermatitis in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
CAT 354, CAT354, CAT-354, LP0162, LP-0162, LP 0162, ILReceptor, IL-13, IL Receptor, Tralokinumab
Target
Caspase, Interleukin, Cadherin, IL Receptor, Apoptosis
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation, Protein Biochemistry, Signal Transduction
Concentration
12.97 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
144.14 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD44 Standard (DF1485), CF405M conjugate, 0.1mg/mL
Complement C4d (C4D204), CF740 conjugate, 0.1mg/mL
